Clinical Trial Update: Triple DAAs Regimen in Treating Non-cirrhotic HCV GT1b Subjects [Phase 2]

View source ↗

Summary

Phase 2 trial update on a triple direct-acting antiviral regimen for non-cirrhotic hepatitis C genotype 1b patients and the study status indicates completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Snippet

Sponsor: Humanity and Health Research Centre | Conditions: Chronic Hepatitis C Infection | Phase 2 | Status: COMPLETED